Altchem Ltd - 19 Oct 2023 Form 4 Insider Report for RVL Pharmaceuticals plc

Role
10%+ Owner
Signature
/s/MILITSA SYMEOU, Altchem Limited, by Militsa Symeou, its Director
Issuer symbol
N/A
Transactions as of
19 Oct 2023
Net transactions value
-$580,147
Form type
4
Filing time
23 Oct 2023, 13:06:00 UTC
Previous filing
20 Oct 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Sale $431,669 -9,363,760 -49% $0.0461 9,700,000 19 Oct 2023 Direct F1
transaction RVLP Ordinary Shares Sale $148,478 -4,758,899 -49% $0.0312 4,941,101 20 Oct 2023 Direct F2
holding RVLP Ordinary Shares 1,182,243 19 Oct 2023 By Self as Sole Manager of Orbit Co-Invest A-1 LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Altchem Ltd is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is the average execution price. These shares were sold in multiple transactions at prices ranging from $0.0400 to $0.0580, inclusive. The reporting person undertakes to provide RVL Pharmaceuticals plc, any security holder of RVL Pharmaceuticals plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is the average execution price. These shares were sold in multiple transactions at prices ranging from $0.0300 to $0.0373, inclusive. The reporting person undertakes to provide RVL Pharmaceuticals plc, any security holder of RVL Pharmaceuticals plc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Represents shares of the Issuer held by Orbit Co-Invest A-1 LLC. Altchem Limited is the sole manager of Orbit Co-Invest A-1 LLC. As a result, Altchem Limited may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest A-1 LLC. Altchem Limited disclaims beneficial ownership of such shares and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.